Abstract
On November 18, 2001, a meeting was held at the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, to discuss the prophylaxis, diagnosis, and treatment of anthrax. Participants included clinicians and health department personnel from areas where anthrax cases were identified, infectious disease experts, representatives of professional societies, and experts from federal agencies. A patient recovering from inhalational anthrax also described her illness. The following is a summary of the presentations and discussion.
Highlights
Using a robust genome phylogeny, we demonstrated the limitations of this method for typing Acinetobacter baumannii
We report a case of severe disseminated infection in an immunocompetent man caused by an emerging lineage of methicillin-sensitive Staphylococcus aureus clonal complex 398
Using whole-genome sequencing, we identified a community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) sequence type (ST) 398 type V (5C2&5) isolate in Australia in 2017
Summary
We aimed to determine whether the incidence of Elizabethkingia species had increased in this hospital and to analyze the risk factors associated with Elizabethkingia acquisition. We aimed to evaluate the effect of an antibiotic cycling policy, derived using time-series analysis of retrospective epidemiologic data, on the incidence of healthcare-associated MRSA (HA-MRSA) and healthcare-associated CDI (HA-CDI). We aimed to implement an antibiotic cycling policy throughout a hospital where the analysis of local epidemiologic data using autoregressive integrated moving average modeling provided the framework for the antibiotic cycling policy. We aimed to characterize the genetics and antigenicity of circulating H9N2 viruses in Pakistan and link the molecular basis of differences seen in circulating viruses with zoonotic potential. We aimed to gain insights for pathogen–host interactions to better inform management practices and reduce risk for FeLV spillover from domestic cats to endangered felid populations
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
